SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Qualified Opinion who wrote (9535)6/22/2006 8:01:07 PM
From: fred hayes  Read Replies (2) of 10280
 
Rob, don't care what they said. Don't think they would terminate I before the fda meeting unless they were buying sepr. I think sepr is for sale and that pfe can't afford to wait. Don't agree it would be a "mistake" to buy SEPR. But you may be right. I don't know. But I think the risk-reward favors buying nbix in this situation for sure. As for looking at pfe, that's where I have a big chunk of my "safe" money. It's like a public utility -- great dividend and solid business. Pfe's price is stupid-low. But the way I look at things, you have to take some chances when you're presented with an offer you can't refuse. That would be nbix now, and the premise that makes nbix look good to me requires PFE to be buying sepr. So, that settles it (:>)...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News